, Etat des lieux et recommandations pour le dépistage du cancer du col de l'utérus en france

, Haute Autorité de Santé, 2016.

, New Canadian Task Force guideline: Start Pap tests at age 25, not 18 | Canadian Women's Health Network, 2017.

A. Anttila, L. Von-karsa, A. Aasmaa, M. Fender, J. Patnick et al., Cervical cancer screening policies and coverage in Europe, Eur J Cancer Oxf Engl, vol.45, pp.2649-58, 1990.

A. White, Cancer Screening Test Use -United States, MMWR Morb Mortal Wkly Rep, vol.66, 2015.

N. Beltzer and . Hamers, PDF) Final results of the evaluation of organized screening for cervical cancer in 13 departments in France, pp.2010-2014

. Researchgate, , pp.13-2010, 2018.

G. Menvielle, J. B. Richard, V. Ringa, R. Dray-spira, and B. F. Baromètre, , 2010.

M. Arbyn, A. O. Raifu, E. Weiderpass, F. Bray, and A. Anttila, Trends of cervical cancer mortality in the member states of the European Union, Eur J Cancer Oxf Engl, vol.45, pp.2640-2648, 1990.

B. Kouchner, P. Guilbert, F. Baudier, and A. Gautier, Baromètre santé, vol.2, 2000.

C. Worthington, K. Mcleish, and E. Fuller-thomson, Adherence over time to cervical cancer screening guidelines: insights from the Canadian National Population Health Survey, J Womens Health, vol.21, pp.199-208, 2002.

C. Rondet, A. Lapostolle, M. Soler, F. Grillo, I. Parizot et al., Are Immigrants and Nationals Born to Immigrants at Higher Risk for Delayed or No Lifetime Breast and Cervical Cancer Screening? The Results from a Population-Based Survey in Paris Metropolitan Area in 2010, PLoS ONE, vol.9, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01369491

S. S. Coughlin, E. S. Breslau, T. Thompson, and V. B. Benard, Physician recommendation for papanicolaou testing among U.S. women, Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol, vol.14, pp.1143-1151, 2000.

R. Martín-lópez, V. Hernández-barrera, D. Andres, A. L. Garrido, P. C. et al., Breast and cervical cancer screening in Spain and predictors of adherence, Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP, vol.19, pp.239-284, 2010.

J. Fish and D. Anthony, UK national lesbians and health care survey, Women Health, vol.41, pp.27-45, 2005.

N. Oussaid, D. Lutringer-magnin, G. Barone, J. Haesebaert, and C. Lasset, Factors associated with pap smear screening among French women visiting a general practitioner in the Rhône-Alpes region, Rev Dépidémiologie Santé Publique, vol.61, pp.437-482, 2013.

D. J. Lee, Training to fit intrauterine devices/intrauterine systems for general practitioners: is there an alternative method of service delivery? J Fam Plann Reprod Health Care, vol.33, pp.205-212, 2007.

K. J. Buhling, B. Hauck, S. Dermout, K. Ardaens, and L. Marions, Understanding the barriers and myths limiting the use of intrauterine contraception in nulliparous women: results of a survey of European/Canadian healthcare providers, Eur J Obstet Gynecol Reprod Biol, vol.183, pp.146-54, 2014.

M. Goldberg, M. Carton, A. Descatha, A. Leclerc, Y. Roquelaure et al., CONSTANCES: a general prospective population-based cohort for occupational and environmental epidemiology: cohort profile, Occup Environ Med, vol.74, pp.66-71, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01881596

M. L. Eisenberg and L. I. Lipshultz, Estimating the number of vasectomies performed annually in the United States: data from the National Survey of family growth, J Urol, vol.184, pp.2068-72, 2010.

N. Bajos, A. Bohet, L. Guen, M. Moreau, and C. De-l'enquête-fécond, La contraception en France : nouveau contexte, nouvelles pratiques ?, 2012.

. Insee, , 2016.

J. Sterne, I. R. White, J. B. Carlin, M. Spratt, P. Royston et al., Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls, BMJ, vol.338, p.2393, 2009.

I. R. White, P. Royston, and A. M. Wood, Multiple imputation using chained equations: issues and guidance for practice, Stat Med, vol.30, pp.377-99, 2011.

K. Moons, R. Donders, T. Stijnen, and F. E. Harrell, Using the outcome for imputation of missing predictor values was preferred, J Clin Epidemiol, vol.59, pp.1092-101, 2006.

V. Hippel and P. T. , Regression with missing ys: an improved strategy for analyzing multiply imputed data, vol.37, pp.83-117, 2007.

J. D. Allen, J. E. Pérez, C. R. Pischke, L. S. Tom, A. Juarez et al., Dimensions of religiousness and cancer screening behaviors among church-going Latinas, J Relig Health, vol.53, pp.190-203, 2014.

N. Duport, Characteristics of women using organized or opportunistic breast cancer screening in France, Rev Dépidémiologie Santé Publique, vol.60, pp.421-451, 2012.

B. T. Hansen, S. S. Hukkelberg, T. Haldorsen, T. Eriksen, G. B. Skare et al., Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women, BMC Public Health, vol.11, p.264, 2011.

C. G. Grindel, L. A. Mcgehee, C. A. Patsdaughter, and S. J. Roberts, Cancer prevention and screening behaviors in lesbians, Women Health, vol.44, pp.15-39, 2006.

A. Smith, W. Heywood, R. Ryall, J. M. Shelley, M. K. Pitts et al., Association between sexual behavior and cervical cancer screening, J Womens Health, vol.20, pp.1091-1097, 2002.

L. K. Mcdonagh, J. M. Saunders, J. Cassell, T. Curtis, H. Bastaki et al., Application of the COM-B model to barriers and facilitators to chlamydia testing in general practice for young people and primary care practitioners: a systematic review, Implement Sci IS, vol.13, p.130, 2018.

R. M. Lubitz, D. K. Litzelman, R. S. Dittus, and W. M. Tierney, Is obesity a barrier to physician screening for cervical cancer?, Am J Med, vol.98, pp.491-497, 1995.

E. Monnet, F. Mauny, A. Marquant, C. Michaud, and J. P. Ferry, Knowledge and participation of general practitioners in cervical cancer screening: survey in a French pilot area, Rev Dépidémiologie Santé Publique, vol.46, pp.108-122, 1998.

A. P. Hossein, Knowledge about cervical Cancer and pap smear and the factors influencing the pap test screening among women, Int J Community Based Nurs Midwifery, vol.5, p.188, 2017.

F. Verdoodt, M. Jentschke, P. Hillemanns, C. S. Racey, P. Snijders et al., Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials, Eur J Cancer Oxf Engl, vol.51, pp.2375-85, 1990.

A. Lim and P. Sasieni, Consultation rates in cervical screening non-attenders: opportunities to increase screening uptake in GP primary care, J Med Screen, vol.22, pp.93-102, 2015.

M. Arbyn, S. B. Smith, S. Temin, F. Sultana, and P. Castle, Collaboration on self-sampling and HPV testing. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses, BMJ, vol.363, p.4823, 2018.

M. Arbyn, F. Verdoodt, P. Snijders, V. Verhoef, E. Suonio et al., Accuracy of human papillomavirus testing on self-collected versus cliniciancollected samples: a meta-analysis, Lancet Oncol, vol.15, pp.172-83, 2014.